New Frontiers of Laser Welding Technology

With the advances in power sources and optic technologies, high-power laser welding has been utilized in many applications such as automotive, battery manufacturing, and electronic industries. The low-heat input of laser power and its precise control enables minimal thermal damage and geometric inaccuracy in the weldment. Recently, laser welding has evolved in combination with machine learning, monitoring and control technology, new materials, and new processes. This Special Issue aims to present the recent advances in the development in innovative laser welding technologies based on new laser power sources, laser optics, systems, and monitoring technologies. A total of six papers are presented in this Special Issue

Role of Binder on Yield Strength of polycaprolactone/dimethylsulfone composites for bio-applications

Polycaprolactone (PCL) and dimethylsulfone (DMSO2) composites can tailor the properties of scaffold materials, allowing their use in bone tissue engineering. With an increase in DMSO2 content, the modulus of the material increases but not the yield strength. In order to increase yield strength, a binder was added. However, the optimization of the content and the mixing process of the binder were not optimized in the previous studies. In this study, gamma-methacryloxypropyltrimethoxysilane (A-174) was used as a binder to increase the strength of a composite. Four different mixing processes were employed based on the binder mixing sequence. The binders with content of 0, 0.4, 0.5, 0.7, and 1.5 phr were employed. The yield strengths of composites were investigated in terms of the binder mixing sequence and binder content. When the binder and DMSO2 particle fillers were premixed in the PCL matrix consisting of a DMSO2 filler and an A-174 binder system, the filler surface was coated smoothly and uniformly, and less agglomeration occurred. The yield strength of the composites with the appropriate mixing sequence was 36.71 % higher than that of the specimen without a binder, which was attributed to the improved adhesion between the matrix and fillers. Upon increasing the binder content, elongation and tearing of the matrix surface were observed in the cross-sections after yield tests; however, the weakening of mechanical anchoring was caused by excessive binder content, and filler debonding was observed on the surface. Because of the use of the A-174 silane binder at a concentration of 0.5 phr and the premixing of the binder and filler, the highest performance in terms of strength improvement of a PCL-20 wt % DMSO2 composite was achieved

Development of Prediction Method for Dimensional Stability of 3D-Printed Objects

Fused deposition modeling (FDM), as one of the additive manufacturing processes, is known for strong layer adhesion suitable for prototypes and end-use items. This study used a multiple regression model and statistical analysis to explore the dimensional accuracy of FDM objects. Factors such as inclination angle, layer thickness, support space, and raster angle were examined. Machine learning models (Gaussian process regression (GPR), support vector machines (SVM), and artificial neural network (ANN)) predicted dimensions using 81 datapoints. The mean squared dimensional error (MSDE) between the measured and designed surface profiles was selected as an output for the dimensional accuracy. Support spacing, layer thickness, and raster angle were determined to be statistically significant, and all factors were confirmed as significant predictors. The coefficients of determination for multiple linear regression, GPR, SVM, and ANN models were 76%, 98%, 93%, and 99%, respectively. The mean absolute errors (MAEs)—errors between the measured and the predicted MSDEs—were 0.020 mm and 0.034 mm, respectively, for GPR and SVM models. The MAEs for ANN models were 0.0055 mm for supporting cases and 2.1468 x 10 -5 mm for non-supporting cases

PCL and DMSO2 Composites for Bio-Scaffold Materials

Polycaprolactone (PCL) has been one of the most popular biomaterials in tissue engineering due to its relatively low melting temperature, excellent thermal stability, and cost-effectiveness. However, its low cell attraction, low elastic modulus, and long-term degradation time have limited its application in a wide range of scaffold studies. Dimethyl sulfone (DMSO2) is a stable and non-hazardous organosulfur compound with low viscosity and high surface tension. PCL and DMSO2 composites may overcome the limitations of PCL as a biomaterial and tailor the properties of biocomposites. In this study, PCL and DMSO2 composites were investigated as a new bio-scaffold material to increase hydrophilicity and mechanical properties and tailor degradation properties in vitro. PCL and DMSO2 were physically mixed with 10, 20, and 30 wt% of DMSO2 to evaluate thermal, hydrophilicity, mechanical, and degradation properties of the composites. The water contact angle of the composites for hydrophilicity decreased by 15.5% compared to pure PCL. The experimental results showed that the mechanical and degradation properties of PCL and DMSO2 were better than those of pure PCL, and the properties can be tuned by regulating DMSO2 concentration in the PCL matrix. The elastic modulus of the composite with 30 wt% of DMSO2 showed 532 MPa, and its degradation time was 18 times faster than that of PCL

Association between prostate-specific antigen and serum testosterone:A systematic review and meta-analysis

Background Serum testosterone assays are an important tool in the clinical evaluation of a number of endocrine disorders including male hypogonadism. However, serum testosterone has a limited role in real clinical use due to its inaccuracy. We aimed to assess the association between prostate-specific antigen (PSA) and testosterone as well as the effects of various types of testosterone replacement therapy (TRT) for PSA level. Methods Two electronic databases were screened: PubMed (1966 through December 2018) and Cochrane Library (1993 through December 2018). The first strategy compared the overall increase in PSA following testosterone treatment compared with placebo. The second strategy analyzed the overall association between PSA and testosterone among the observational studies. Results In the first strategy, 22 articles were included in the final analysis. In the second strategy, 18 studies were included. Testosterone replacement therapy (TRT) showed a significant change in PSA level compared to that in the placebo group (mean difference [MD]: 0.13, 95% CI: 0.01-0.25, P = .04). Compared to placebo, only intramuscular (IM) TRT shows a significant change in PSA level group (MD: 0.16, 95% CI: 0.01-0.30, P = .04), as neither the oral nor topical type showed a significant change in PSA. In the second strategy analysis, there was no overall correlation found between PSA and testosterone (z = 0.04, 95% CI: -0.04 to 0.12, P = .04; r = 0.039). However, in the subgroup of non-BPH (benign prostate hyperplasia), a significant correlation between PSA and testosterone (z = 0.07, 95% CI: 0.01-0.13, P = .009; r = 0.089) was found. Conclusions We found that TRT, particularly IM TRT, significantly changed the PSA level compared with the placebo group. Furthermore, there was a significant correlation between PSA and testosterone in patients with non-BPH. According to these findings, we suggest the possibility of PSA as a surrogate marker of testosterone